Novo Nordisk A/S (NONOF)
51.20
-0.30
(-0.58%)
USD |
OTCM |
Dec 30, 15:42
Novo Nordisk Market Cap: 227.51B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 966.71B |
| Genmab A/S | 19.36B |
| Ascendis Pharma A/S | 12.79B |
| Evaxion AS | 30.13M |
Market Cap Related Metrics
| PE Ratio | 14.91 |
| PS Ratio | 4.885 |
| PEG Ratio | 1.317 |
| Price to Book Value | 8.507 |
| Price to Free Cash Flow | 24.56 |
| Price | 51.20 |
| Earnings Yield | 6.70% |
| PEGY Ratio | 1.016 |
| Operating PE Ratio | 11.52 |
| Normalized PE Ratio | 14.91 |